Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Low-cost index funds offer broad diversification with minimal fees. This guide explains how to choose funds that track wide market indexes for retirement.
26,677 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Oracle stock drop today? sent shockwaves through the tech arena as investors weigh cloud strategy and AI momentum. Th...
A century-and-a-half-old Indiana company is drawing fresh investor attention with a plan to become the world's larges...
A disrupted energy flow landscape is lifting a U.S. midstream stock and with it the focus on safe, high-yield income....
Goldman Sachs names Marvell Technology and Micron Technology as the linchpins of the next AI deployment cycle, elevat...
Pi Network shows resilience as the protocol upgrade cycle continues. The token rebounds from a key $0.13 support leve...
An overnight run on a DeFi vault led to a wind-down after $8.5 million was redeemed, highlighting liquidity risk for ...
New York’s Democratic primaries produced surprising wins for a progressive slate, with Gaza policy shaping fundraisin...
The Supreme Court ruled 5-4 that ballots postmarked by Election Day can be counted in many states, avoiding last-minu...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...